Zihui Xu

Ms. Zihui Xu

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in Science Advances
Verified
Journal Article
Open access
ZHZhaohuan Huang
Zhaohuan Huang
LLLing Liu
Ling Liu
JZJian Zhang
Jian Zhang
KCKristine Conde
Kristine Conde
JPJay Phansalkar
Jay Phansalkar
JLJi Liu
Ji Liu
Glucagon-like peptide-1 (GLP-1) regulates energy homeostasis via activation of the GLP-1 receptors (GLP-1Rs) in the central nervous system. However, the mechanism by which the central GLP-1 signal controls blood glucose levels, especially in different nutrient states, remains unclear. Here, we defined a population of glucose-sensing GLP-1R neurons in the dorsomedial hypothalamic nucleus (DMH), by which endogenous GLP-1 decreases glucose levels via the cross-talk between the hypothalamus and pancreas. Specifically, we illustrated the sufficiency and necessity of DMH GLP-1R in glucose regulation. The activation of the DMH GLP-1R neurons is mediated by a cAMP-PKA–dependent inhibition of a delayed rectifier potassium current. We also dissected a descending control of DMH GLP-1R –dorsal motor nucleus of the vagus nerve (DMV)–pancreas activity that can regulate glucose levels by increasing insulin release. Thus, our results illustrate how central GLP-1 action in the DMH can induce a nutrient state–dependent reduction in blood glucose level.

Verified
Journal Article
Open access
PDF file
ZZZuming Zhang
Zuming Zhang
ZXZihui Xu
Zihui Xu
FYFa Yuan
Fa Yuan
KJKangxin Jin
Kangxin Jin
MXMengqing Xiang
Mengqing Xiang
It is difficult to regenerate mammalian retinal cells once the adult retina is damaged, and current clinical approaches to retinal damages are very limited. The introduction of the retinal organoid technique empowers researchers to study the molecular mechanisms controlling retinal development, explore the pathogenesis of retinal diseases, develop novel treatment options, and pursue cell/tissue transplantation under a certain genetic background. Here, we revisit the historical background of retinal organoid technology, categorize current methods of organoid induction, and outline the obstacles and potential solutions to next-generation retinal organoids. Meanwhile, we recapitulate recent research progress in cell/tissue transplantation to treat retinal diseases, and discuss the pros and cons of transplanting single-cell suspension versus retinal organoid sheet for cell therapies.

12 April 2023 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JWJia-Ru Wei
Jia-Ru Wei
DXDongchang Xiao
Dongchang Xiao
LTLei Tang
Lei Tang
NXNana Xu
Nana Xu
RLRuifeng Liu
Ruifeng Liu
SLSheng Liu
Sheng Liu

30 January 2013 in Journal of Biotechnology
Verified
Journal Article
Closed access
KZKebin Zhang
Kebin Zhang
HYHua Yu
Hua Yu
WXWei Xie
Wei Xie
ZXZihui Xu
Zihui Xu
SZShiwen Zhou
Shiwen Zhou
GQGuisheng Qian
Guisheng Qian

23 September 2023 in Cell Proliferation
Verified
Journal Article
Open access
ZXZihui Xu
Zihui Xu
YGYanan Guo
Yanan Guo
KXKangjian Xiang
Kangjian Xiang
DXDongchang Xiao
Dongchang Xiao
MXMengqing Xiang
Mengqing Xiang
Glaucoma and other optic neuropathies lead to progressive and irreversible vision loss by damaging retinal ganglion cells (RGCs) and their axons. Cell replacement therapy is a potential promising treatment. However, current methods to obtain RGCs have inherent limitations, including time‐consuming procedures, inefficient yields and complex protocols, which hinder their practical application. Here, we have developed a straightforward, rapid and efficient approach for directly inducing RGCs from mouse embryonic fibroblasts (MEFs) using a combination of triple transcription factors (TFs): ASCL1, BRN3B and PAX6 (ABP). We showed that on the 6th day following ABP induction, neurons with molecular characteristics of RGCs were observed, and more than 60% of induced neurons became iRGCs (induced retinal ganglion cells) in the end. Transplanted iRGCs had the ability to survive and appropriately integrate into the RGC layer of mouse retinal explants and N‐methyl‐D‐aspartic acid (NMDA)‐damaged retinas. Moreover, they exhibited electrophysiological properties typical of RGCs, and were able to regrow dendrites and axons and form synaptic connections with host retinal cells. Together, we have established a rapid and efficient approach to acquire functional RGCs for potential cell replacement therapy to treat glaucoma and other optic neuropathies.

7 February 2024 in Cell Proliferation
Verified
Journal Article
Open access
ZXZihui Xu
Zihui Xu
YGYanan Guo
Yanan Guo
KXKangjian Xiang
Kangjian Xiang
DXDongchang Xiao
Dongchang Xiao
MXMengqing Xiang
Mengqing Xiang
The cover image is based on the Original Article Rapid and efficient generation of a transplantable population of functional retinal ganglion cells from fibroblasts by Zihui Xu et al., https://doi.org/10.1111/cpr.13550. image